Skip to main content
Premium Trial:

Request an Annual Quote

BU and Fraunhofer to Develop Arrays for Dx Applications

NEW YORK (GenomeWeb News) — Boston University’s College of Engineering yesterday said it will partner with German biotech Fraunhofer to develop microarrays for molecular diagnostic applications.
 
When it begins in January, the so-called BU-Fraunhofer Alliance for Medical Devices, Instrumentation and Diagnostics will be a 5-year, $5-million jointly funded initiative that will work with the school’s Department of Biomedical Engineering.
 
Andrew Sharon, director of the Fraunhofer Center for Manufacturing and Innovation, said the alliance will create disposable chips for molecular-level disease diagnosis.
 
The firm will fabricate DNA and peptide arrays and perform translational research with the medical school, Sharon said. “We are trying to develop new devices and methods that will accelerate the process of moving research to the medical application.”
 
Munich-based Fraunhofer is involved in various hi-tech research fields and several biomedical areas, including medical imaging and array-based diagnostics.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.